| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-P0294 |
Hexa-His |
|
99.84% |
Unkown |
| HY-P1028 |
Hexa-D-arginine |
|
99.97% |
Unkown |
| HY-104050 |
M-31850 |
|
99.79% |
Unkown |
| HY-N7698B |
Hexa-N-acetylchitohexaose |
Substrate |
99.81% |
Unkown |
| HY-W142015 |
Hexa-L-Tyrosine |
|
99.88% |
Unkown |
| HY-P1028A |
Hexa-D-arginine TFA |
|
99.01% |
Unkown |
| HY-W017690 |
(2E,4E)-Hexa-2,4-dien-1-ol |
|
98.81% |
Unkown |
| HY-W068700 |
Methyl sorbate |
|
98.85% |
Unkown |
| HY-P0294A |
Hexa-His TFA |
|
99.77% |
Unkown |
| HY-N4308 |
Hexamethylquercetagetin |
Inhibitor |
98.0% |
Unkown |
| HY-W753474 |
1,2-Dipalmitelaidoyl-sn-glycero-3-phosphocholine |
|
99% |
Unkown |
| HY-132190 |
Hexanolamino PAF C-16 |
Antagonist |
99.9% |
Unkown |
| HY-141510A |
myo-Inositol trispyrophosphate hexa-triethylamine |
|
98.0% |
Unkown |
| HY-108241A |
Galacto-PUGNAc |
Inhibitor |
/ |
Unkown |
| HY-E71548 |
2-Hydroxy-6-oxo-6-(2-aminophenyl)hexa-2,4-dienoate hydrolase |
|
/ |
Unkown |
| HY-P4247 |
Hexaarginine |
|
/ |
Unkown |
| HY-RS06142 |
HEXA Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W112661 |
2,3,6,7,10,11-Hexapyridine-3-yltriphenylene |
|
/ |
Unkown |
| HY-W112926 |
1,2,3,4,5,6-Hexa(1H-imidazol-1-yl)benzene |
|
/ |
Unkown |
| HY-W243917 |
4-[[2,3,4,4,6-Pentakis(4-carboxyphenoxy)-1,3,5-triaza-2,4λ5,6-triphosphacyclohex-4-en-1-yl]oxy]benzoicacid |
|
/ |
Unkown |
| HY-W423439 |
1,2,3,4,5,6-Hexa(pyridin-4-yl)benzene |
|
/ |
Unkown |
| HY-W456296 |
N1,N1,N3,N3,N5,N5-Hexa(pyridin-4-yl)benzene-1,3,5-triamine |
|
/ |
Unkown |
| HY-W578017 |
N2,N2,N4,N4,N6,N6-Hexa-2-pyridinyl-1,3,5-triazine-2,4,6-triamine |
|
/ |
Unkown |
| HY-W802269 |
3,6,2',3',4',6'-Hexa-O-acetyl-D-lactal |
|
/ |
Unkown |
| HY-175148 |
Hexa lipid 114 |
|
/ |
Unkown |
| HY-N13438 |
6beta-(Hexa-2,4-dienoyloxy)-9alpha,12-dihydroxydrimenol |
|
/ |
Unkown |
| HY-RS17493 |
Hexa Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS23950 |
Hexa Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |